Team:EPF-Lausanne/Safety
From 2009.igem.org
(Difference between revisions)
(→Our project's safety issues) |
(→iGEM questions) |
||
Line 30: | Line 30: | ||
==iGEM questions== | ==iGEM questions== | ||
- | 1. Would any of your project ideas raise safety issues in terms of: | + | 1. Would any of your project ideas raise safety issues in terms of: researcher safety, public safety, or environmental safety? |
- | + | No | |
- | + | ||
- | + | ||
- | + | ||
2. Is there a local biosafety group, committee, or review board at your institution? | 2. Is there a local biosafety group, committee, or review board at your institution? | ||
- | + | Yes | |
3. What does your local biosafety group think about your project? | 3. What does your local biosafety group think about your project? | ||
+ | ... -> Aller voir Stéphane Karlen lundi. AAB 025. | ||
+ | 4. Do any of the new BioBrick parts that you made this year raise any safety issues?If yes, did you document these issues in the Registry? | ||
+ | No | ||
- | + | <br><br><br> | |
- | + | ||
==Conclusions== | ==Conclusions== |
Revision as of 12:39, 18 October 2009
Our project's safety issues
Our project is considered as a risk Class 1 :
Class 1: GMOs or pathogen agents that are generally speaking harmless for humans.
EPFL Biosafety
[http://biosafety.epfl.ch/page59210-en.html Biosafery website]
hahaha
iGEM questions
1. Would any of your project ideas raise safety issues in terms of: researcher safety, public safety, or environmental safety? No
2. Is there a local biosafety group, committee, or review board at your institution? Yes
3. What does your local biosafety group think about your project? ... -> Aller voir Stéphane Karlen lundi. AAB 025.
4. Do any of the new BioBrick parts that you made this year raise any safety issues?If yes, did you document these issues in the Registry? No
Conclusions
bla